Cargando…

Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial

IMPORTANCE: Understanding why and how extremely preterm infants die is important for practitioners caring for these infants. OBJECTIVE: To examine risk factors, causes, timing, and circumstances of death in a modern cohort of extremely preterm infants. DESIGN, SETTING, AND PARTICIPANTS: A retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juul, Sandra E., Wood, Thomas R., Comstock, Bryan A., Perez, Krystle, Gogcu, Semsa, Puia-Dumitrescu, Mihai, Berkelhamer, Sara, Heagerty, Patrick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822378/ https://www.ncbi.nlm.nih.gov/pubmed/35129596 http://dx.doi.org/10.1001/jamanetworkopen.2021.46404

Ejemplares similares

Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2021)

Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2022)

Patterns of Infections among Extremely Preterm Infants
por: Perez, Krystle, et al.
Publicado: (2023)

Predicting 2-year neurodevelopmental outcomes in extremely preterm infants using graphical network and machine learning approaches
por: Juul, Sandra E., et al.
Publicado: (2022)

Diffusion Tensor Imaging Changes Do Not Affect Long-Term Neurodevelopment following Early Erythropoietin among Extremely Preterm Infants in the Preterm Erythropoietin Neuroprotection Trial
por: Law, Janessa B., et al.
Publicado: (2021)

Contemporary Definitions of Infant Growth Failure and Neurodevelopmental and Behavioral Outcomes in Extremely Premature Infants at Two Years of Age
por: Strobel, Katie, et al.
Publicado: (2023)

Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial
por: Wood, Thomas R., et al.
Publicado: (2021)

Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants
por: Curtis, Samantha, et al.
Publicado: (2023)

Time to Regain Birthweight and Association with Neurodevelopmental Outcomes among Extremely Preterm Newborns
por: Valentine, Gregory, et al.
Publicado: (2023)

Neuroprotective potential of erythropoietin in neonates; design of a randomized trial
por: Juul, Sandra E., et al.
Publicado: (2015)

Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update
por: Fischer, Hendrik S., et al.
Publicado: (2021)

Treatment for hypotension in the first 24 postnatal hours and the risk of hearing loss among extremely low birth weight infants
por: Gogcu, Semsa, et al.
Publicado: (2020)

Neuroprotection in Preterm Infants
por: Berger, R., et al.
Publicado: (2015)

Dilemmas of modern neonatology: care of extremely preterm infants
por: Rajendram, Shakina, et al.
Publicado: (2023)

Obstetricians’ Attitudes Toward the Treatment of Extremely Preterm Infants in China
por: Han, Tao, et al.
Publicado: (2022)

Sexually dimorphic methylation patterns characterize the placenta and blood from extremely preterm newborns
por: Santos, Hudson P., et al.
Publicado: (2023)

Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report
por: Luciano, R., et al.
Publicado: (2015)

Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy: A Secondary Analysis of the HEAL Randomized Clinical Trial
por: Juul, Sandra E., et al.
Publicado: (2023)

Frequency of Acute Kidney Injury and Association With Mortality Among Extremely Preterm Infants
por: Aziz, Khyzer B., et al.
Publicado: (2022)

Neonatal Outcomes of Moderately Preterm Infants Compared to Extremely Preterm Infants
por: WALSH, Michele C., et al.
Publicado: (2017)

Safety and Short-term Outcomes of High-Dose Erythropoietin in Preterm Infants With Intraventricular Hemorrhage: The EpoRepair Randomized Clinical Trial
por: Wellmann, Sven, et al.
Publicado: (2022)

The management of extremely preterm infants
por: Mosca, Fabio, et al.
Publicado: (2014)

The Microbiota of the Extremely Preterm Infant
por: Underwood, Mark A., et al.
Publicado: (2017)

Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
por: Ehrhardt, Harald, et al.
Publicado: (2023)

Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage
por: Song, Juan, et al.
Publicado: (2021)

Assessment of Seasonality and Extremely Preterm Birth in Denmark
por: Hviid, Anders, et al.
Publicado: (2022)

Use of Intranasal Insulin as Neuroprotection From Hyperglycemia in Rat Model of Extremely Preterm Infants
por: Yauch, Lauren McClure, et al.
Publicado: (2021)

Racial/Ethnic Disparities Among Extremely Preterm Infants in the United States From 2002 to 2016
por: Travers, Colm P., et al.
Publicado: (2020)

Encephalopathy in Preterm Infants: Advances in Neuroprotection With Caffeine
por: Yang, Liu, et al.
Publicado: (2021)

Recombinant human erythropoietin improves neurological outcomes in very preterm infants
por: Song, Juan, et al.
Publicado: (2016)

Mortality and Morbidity of Infants Born Extremely Preterm at Tertiary Medical Centers in China From 2010 to 2019
por: Zhu, Zhicheng, et al.
Publicado: (2021)

Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants
por: Jensen, Erik A., et al.
Publicado: (2023)

Endogenous erythropoietin concentrations and association with retinopathy of prematurity and brain injury in preterm infants
por: Fahim, Nancy M., et al.
Publicado: (2021)

Editorial: Respiratory Management of Extremely Preterm Infants
por: Özkan, Hasan, et al.
Publicado: (2021)

Acute Otitis Media in an Extremely Preterm Infant
por: Janwadkar, Aashika, et al.
Publicado: (2021)

Near-Infrared Spectroscopy in Extremely Preterm Infants
por: Pavlek, Leeann R., et al.
Publicado: (2021)

Analysis of Factors Associated With Body Mass Index at Ages 18 and 36 Months Among Infants Born Extremely Preterm
por: Murano, Yayoi, et al.
Publicado: (2021)

Risk Factors Associated with Retinopathy of Prematurity in Very and Extremely Preterm Infants
por: Borțea, Claudia Ioana, et al.
Publicado: (2021)

Evaluation of Health-Related Values and Preferences of Adults Who Were Preterm Infants and Parents of Preterm Infants Concerning Use of Prophylactic Cyclooxygenase Inhibitor Drugs
por: Mitra, Souvik, et al.
Publicado: (2023)

Association of Intraventricular Hemorrhage and Death With Tocolytic Exposure in Preterm Infants
por: Pinto Cardoso, Gaëlle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_iddrkmqj3u15nh4fk522bl61a6